HBC’S PROGO BIOACTIVE PEPTIDES NOW IS A “NEW DIETARY INGREDIENT” (NDI) FOR THE US FDA

JON OLAV ØDEGÅRD APPOINTED NEW CEO OF HBC

NOTIFIABLE TRANSACTION – REDELIVERY OF SHARES

DISCLOSURE OF LARGE SHAREHOLDING – AQUA-SPARK

NOTIFIABLE TRANSACTIONS IN CONNECTION WITH PRIVATE PLACEMENT

PRIVATE PLACEMENT SUCCESSFULLY PLACED

CONTEMPLATED PRIVATE PLACEMENT

CORRECTION: MANDATORY NOTIFICATION OF TRADE

MANDATORY NOTIFICATION OF TRADE

FIRST QUARTER 2022 FINANCIAL REPORT